• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Recent Advances in the Application of 1270357-74-8 and 1-(6-Fluoropyridin-2-yl)ethan-1-amine in Chemical Biology and Pharmaceutical Research

The chemical compound with CAS number 1270357-74-8 and its derivative, 1-(6-Fluoropyridin-2-yl)ethan-1-amine, have recently garnered significant attention in the field of chemical biology and pharmaceutical research. These compounds are being extensively studied for their potential applications in drug discovery and development, particularly in the design of novel therapeutic agents targeting various diseases. This research brief aims to provide an overview of the latest findings related to these compounds, highlighting their chemical properties, biological activities, and potential therapeutic applications.

Recent studies have demonstrated that 1270357-74-8 exhibits unique chemical properties that make it a promising candidate for the synthesis of bioactive molecules. Its structural features allow for versatile modifications, enabling researchers to explore a wide range of derivatives with potential pharmacological activities. Among these derivatives, 1-(6-Fluoropyridin-2-yl)ethan-1-amine has emerged as a particularly interesting compound due to its favorable pharmacokinetic properties and selective binding affinity for specific biological targets.

In a study published in the Journal of Medicinal Chemistry, researchers investigated the synthesis and biological evaluation of 1-(6-Fluoropyridin-2-yl)ethan-1-amine as a potential inhibitor of a key enzyme involved in inflammatory pathways. The results indicated that this compound exhibited significant inhibitory activity, with an IC50 value in the nanomolar range. Furthermore, in vitro and in vivo studies demonstrated its ability to reduce inflammation markers, suggesting its potential as a lead compound for the development of anti-inflammatory drugs.

Another area of research focuses on the application of 1270357-74-8 and its derivatives in oncology. A recent preprint article on bioRxiv reported the discovery of a novel series of compounds derived from 1270357-74-8 that showed potent antiproliferative effects against several cancer cell lines. Mechanistic studies revealed that these compounds induce apoptosis through the activation of specific signaling pathways, highlighting their potential as anticancer agents. The study also emphasized the importance of the fluoropyridine moiety in 1-(6-Fluoropyridin-2-yl)ethan-1-amine for enhancing cellular uptake and target engagement.

In addition to its therapeutic potential, 1-(6-Fluoropyridin-2-yl)ethan-1-amine has also been explored as a building block in the synthesis of more complex molecules. A recent patent application disclosed the use of this compound in the preparation of heterocyclic compounds with improved metabolic stability and bioavailability. This innovation could pave the way for the development of next-generation pharmaceuticals with enhanced therapeutic profiles.

Despite these promising findings, challenges remain in the optimization and clinical translation of compounds based on 1270357-74-8 and 1-(6-Fluoropyridin-2-yl)ethan-1-amine. Issues such as off-target effects, metabolic stability, and formulation need to be addressed through further research. However, the ongoing studies and recent advancements underscore the potential of these compounds to contribute significantly to the field of chemical biology and drug discovery.

In conclusion, the latest research on 1270357-74-8 and 1-(6-Fluoropyridin-2-yl)ethan-1-amine highlights their versatility and potential in various therapeutic areas. From anti-inflammatory agents to anticancer drugs, these compounds offer exciting opportunities for the development of novel pharmaceuticals. Continued exploration of their chemical and biological properties will be crucial for unlocking their full potential and translating these findings into clinically relevant therapies.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)